2.800
−6,67%
2026-10-16
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +39.4% | +164.7% | 3 / 3 | -5.8% | -0.77 pp | +0.33 pp | +1.1% | 0.00 | 25.28 | 57,6 | −5,8% | 0,6 | +39,4% | 25.28 | 47.06 | −46,3% |
| Pts | 8 | 12 | 12 | 0 | 4 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 2.800 (close price on 2026-10-16)EPS (TTM): 110,8
Financial charts
1.Revenue & growth
VND bn57,6Q2/26
1.Revenue & growth
VND bn57,6Q2/26
2.Profit & growth
VND bn0,59Q2/26
3.Profit mix (Penman)
VND bn1,10Q2/26
4.Margins & cost structure
%9.2%Q2/26
5.Returns & cash cycle
% · days-0.4%Q2/26
6.Earnings quality & cash
VND bn0,38Q2/26
7.Asset structure
VND bn136Q2/26
8.Funding & debt health
VND bn · times136Q2/26
9.Revenue backlog
VND bn0,19Q2/26
10.Valuation
times · %25,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %60Q2/26
Adjusted EPS growth, latest quarter
39.4%
Average adjusted EPS growth, 3 quarters
193%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26